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Background: The products of protein breakdown in the human colon are considered to be detrimental to gut
health. Amino acid catabolism leads to the formation of sulfides, phenolic compounds and amines, which are
inflammatory and/or precursors to the formation of carcinogens, including N-nitroso compounds. The aim of this
study was to investigate the kinetics of protein breakdown and the bacterial species involved.
Results: Casein, pancreatic casein hydrolysate (mainly short-chain peptides) or amino acids were incubated in vitro
with suspensions of faecal bacteria from 3 omnivorous and 3 vegetarian human donors. Results from the two
donor groups were similar. Ammonia production was highest from peptides, followed by casein and amino acids,
which were similar. The amino acids metabolized most extensively were Asp, Ser, Lys and Glu. Monensin inhibited
the rate of ammonia production from amino acids by 60% (P = 0.001), indicating the involvement of Gram-positive
bacteria. Enrichment cultures were carried out to investigate if, by analogy with the rumen, there was a significant
population of asaccharolytic, obligately amino acid-fermenting bacteria (‘hyper-ammonia-producing’ bacteria; HAP)
in the colon. Numbers of bacteria capable of growth on peptides or amino acids alone averaged 3.5% of the total
viable count, somewhat higher than the rumen. None of these were HAP, however. The species enriched included
Clostridium spp., one of which was C. perfringens, Enterococcus, Shigella and Escherichia coli.
Conclusions: Protein fermentation by human faecal bacteria in the absence of sugars not only leads to the
formation of hazardous metabolic products, but also to the possible proliferation of harmful bacteria. The kinetics of
protein metabolism were similar to the rumen, but HAP bacteria were not found.
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Protein is an abundant substrate for bacterial growth in
the human intestine, possibly more so than carbohydrate
in the distal colon [1]. Some of the protein may be of
dietary origin, but large intestinal fermentation probably
depends more on endogenous sources, including mucus
and host proteins and bacterial protein resulting from
bacterial cell turnover. The metabolism of protein and
its peptide and amino acid hydrolysis products by co-
lonic bacteria can lead to the formation of several by-* Correspondence: john.wallace@abdn.ac.uk
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distribution, and reproduction in any mediumproducts that may be hazardous to health [2]. N-nitroso
compounds are formed from amines and amides, which
in turn arise from the metabolism of amino acids; they
are heavily implicated in the etiology of colorectal cancer
[3]. Hydrogen sulfide is a product of the breakdown of
cysteine and methionine; sulfides induce hyperprolifera-
tion of crypt cells [4], and predispose to colonic carcin-
omas [5] and ulcerative colitis [6]. Other potentially
toxic products of protein breakdown in the large intes-
tine include phenols, ammonia and indoles [7]. Thus,
understanding the processes and bacteria that carry out
proteolysis and its subsequent reactions is highly rele-
vant to human gut health.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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well characterized [1,8,9], and some aspects of the me-
tabolism of peptides are known [1,10]. Bacterial species
able to grow on individual amino acids as N and energy
source are fairly well understood [11]. They include
many of the ‘putrefactive’ Clostridium, Peptostreptococ-
cus and Fusobacterium species [11,12]. Some evidence
that gut bacteria can also use Stickland reactions, which
involves the coupled oxidation and reduction of pairs of
amino acids to organic acids [13], was obtained by Smith
and Macfarlane [1]. However, bacteria able to grow on a
mixture of protein breakdown products, although known
to be numerous [11], have not been characterized. It is
possible that the species that derive energy from protein
in the colon are among the most numerous species
which, when carbohydrate has been exhausted, switch to
amino acids as a substrate for generating metabolic en-
ergy. It is also possible, however, that a less numerous,
high-activity functional group of deaminative bacteria
exists, analogous to the ‘hyper-ammonia-producing’
(HAP) bacteria of the rumen [14-18]. These asaccharoly-
tic bacteria generate NH3 at a rate far greater than the
most numerous ruminal species, such that, although
their population size is small, they may make a signifi-
cant contribution to overall NH3 production in the
rumen of cattle and sheep. Attention has been paid to
these bacteria because of their impact on N retention in
the animal. If they were to exist in the human colon,
they might have a similar significance, except to human
health rather than nutrition. They might also be subject
to dietary manipulation, as in the rumen [18,19]. The
aim of the present work was therefore to investigate the
properties of NH3 production from protein in the colon,
and to use methods that revealed the ruminal HAP
population to determine if HAP populations also exist in
the human colonic microbiota.Table 1 Ammonia production from peptides (Trypticase) and
and without added 5 μM monensin
Substrate
Donor O1 O2 O3
Trypticase 1.44 1.39 1.62
Amino acids 1.00 0.94 1.13
Trypticase +monensin 0.88 0.80 1.01
Amino acids +monensin 0.50 0.30 0.43
P values
Trypticase vs amino acids <0.001
Monensin <0.001
Trypticase vs amino acids × monensin 0.866
O or V, Trypticase vs amino acids 0.648
O or V, monensin, 0.631Results
Ammonia production in faecal suspensions in vitro
The rate of NH3 production by mixed faecal bacteria
depended on the donor and the substrate. Six samples
were investigated for their activity with Trypticase, a pan-
creatic casein hydrolysate containing predominantly pep-
tides, and an amino acid mixture formulated to contain
the same amino acid composition (Table 1). There were
significant differences (P < 0.001) between production
rates on Trypticase and amino acids, and the production
rate was decreased by monensin (P < 0.001) but there was
no interaction (P = 0.866). Activities were similar in the 3
samples from omnivores and in one sample from a vege-
tarian, while one vegetarian sample had about half the
average activity and the other double the average. The
type of subject diet did not affect production rate (P =
0.678). In a different set of samples from donors O1, O2
and V1, the rate of NH3 production from casein was 19%
lower than from Trypticase (P = 0.04) and not different
from amino acids (P >0.05) (results not shown). Monensin
had a greater effect on NH3 production from amino acids
(60% inhibition) compared to peptides (Trypticase; 39%
inhibition) (Table 1; P = 0.003).
Amino acid analysis revealed that total amino acid break-
down was slightly greater with peptides than amino acids,
but the effect was not significant (Table 2). No amino acid
was degraded completely during the course of the incuba-
tions. The order of rates of disappearance of different
amino acids was also similar for both substrates, with Glu,
Asp, Ser and Lys being most rapidly degraded and the aro-
matic amino acids, Phe and Tyr, being most resistant to
degradation. Tryptophan was not present in the analysis be-
cause it was destroyed during the acid hydrolysis method
used to hydrolyse samples. Monensin had a major inhibi-
tory effect on the breakdown of amino acids in both sub-
strates, with an inhibition of 61% with amino acids and 48%amino acids by mixed human faecal bacteria in vitro with
Rate of ammonia production
(μmol (mg protein)-1 h-1)
V1 V2 V3 Mean SE
0.65 3.03 1.71 1.64 0.39
0.40 2.30 1.04 1.14 0.31
0.50 2.04 0.80 1.00 0.27
0.28 0.96 0.31 0.46 0.13
Table 2 Amino acid utilization from peptides (Trypticase) and amino acids by mixed human faecal bacteria in vitro
with and without added 5 μM monensin
Amino acids Amino
acids +
monensin
Trypticase Trypticase
+monensin
P value
Meana SE Mean SE Mean SE Mean SE Trypticase vs amino
acids
Effect of monensin, amino
acids
Effect of monensin,
trypticase
ASP 0.673 0.171 0.650 0.170 0.754 0.159 0.570 0.160 NS NS 0.050
GLU 1.460 0.367 −0.155 0.153 1.356 0.363 0.532 0.276 NS 0.005 0.006
SER 0.804 0.103 0.539 0.148 0.735 0.106 0.535 0.130 NS NS NS
GLY 0.414 0.086 0.056 0.044 0.386 0.052 0.092 0.039 NS 0.005 0.001
HIS 0.178 0.030 0.055 0.023 0.200 0.029 0.077 0.029 NS 0.006 0.018
ARG 0.255 0.034 0.217 0.042 0.347 0.035 0.339 0.070 NS NS NS
THR 0.361 0.083 0.156 0.047 0.626 0.063 0.343 0.080 0.005 0.023 0.007
ALA 0.139 0.053 −0.027 0.041 0.207 0.042 0.032 0.050 NS 0.034 0.000
PRO 0.468 0.157 0.067 0.100 0.685 0.171 0.055 0.094 NS 0.013 0.012
TYR 0.078 0.031 0.024 0.019 0.062 0.013 0.031 0.014 NS 0.015 0.009
VAL 0.132 0.062 0.026 0.051 0.153 0.037 0.070 0.042 NS NS NS
ILE 0.140 0.054 0.040 0.040 0.178 0.038 0.088 0.023 NS 0.022 NS
LEU 0.278 0.097 0.151 0.098 0.343 0.082 0.250 0.097 NS 0.025 NS
PHE 0.094 0.031 0.042 0.024 0.149 0.031 0.082 0.015 NS 0.014 NS
LYS 0.542 0.130 0.396 0.146 0.764 0.166 0.498 0.164 0.043 0.014 NS
Total 6.017 1.214 2.237 0.907 6.946 0.976 3.596 0.658 NS 0.011 0.005
aμmol amino acid metabolised h-1 ml-1, n = 6.
NS, P > 0.05.
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with different amino acids and according to the sub-
strate. The breakdown of free Glu and Ala was com-
pletely inhibited, resulting in slight net synthesis, and
Pro metabolism decreased by 86%. In contrast, break-
down of Asp in the amino acids mixture was un-
affected by monensin, and Arg breakdown was
inhibited only by 15% For the most part, monensin
inhibited amino acid dissimilation to the same extent,
whether present in peptides or amino acids. Again,
Glu was an exception, its metabolism being inhibited
less when present in peptide form.
Assessment of population size of bacteria capable of
growth on peptides and amino acids
When dilutions of faecal bacteria were inoculated into li-
quid media in anaerobic culture tubes, both the number
of tubes showing growth and the cell density achieved
increased with the time of incubation. Numbers on
complete medium generally reached a plateau at 2 d,
while growth on the other, sugars-free media usually
reached a maximum at 4 d, although because a few
increases were observed between 4 and 7 d, 7-d values
were used to calculate bacterial numbers (Figure 1).
Total numbers approached 1010 (g wet wt)-1, while num-
bers capable of growing on sugar-free media after 7 d
were about 108 (g wet wt)-1. Actual counts on Trypticasemedium varied from 0.8 × 107 to 3.5 × 108 (g wet wt)-1.
Monensin decreased numbers in Trypticase medium by
an average of 92% to 105-106 (g wet wt)-1. Amino acid
utilizers were on average only slightly (26%) fewer in
number than Trypticase utilizers.
Bacterial isolates
A total of 53 isolates was isolated from the highest dilu-
tions of faecal bacteria from two ominivores and one
vegetarian. Twenty-eight survived repeated sub-culture,
of which 24 gave full length or near full length 16S
rRNA gene sequences (Table 3). The remaining four
were identified from partial sequences. None of the
isolates was asaccharolytic, growth being increased
significantly in all cases by the addition of glucose to
the medium. The bacteria enriched from the faecal samples
appeared to be different depending on whether the
substrate was peptides or amino acids. Shigella spp.
and E. coli were more numerous in the amino acids-
containing cultures. Other pathogens that were
enriched included Enterococcus faecalis, Staphylococcus
sp. and Eggerthella lenta.
Discussion
The measurements made here of rates of NH3 production
from different amino acid-containing substrates, the influ-
ence of monensin on these rates, and the properties of
Figure 1 Most-probable-numbers (MPN) counts of Trypticase and amino acid-utilising bacteria in faeces from human omnivorous
(O2 and O3) and vegetarian (V1 and V2) donors. Results are from 7-d counts. Error bars represent 95% confidence levels.
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Trypticase have important implications for understanding
the biochemistry and microbial ecology of amino acid me-
tabolism, and therefore the production of potentially haz-
ardous products that can be formed from amino acids and
related nitrogenous compounds in the human colon [2].
These results add to the substantial body of knowledge
generated by Smith and Macfarlane [1,8-11,20] in the fol-
lowing respects. Ammonia production from peptides and
amino acids was compared in diluted fresh samples of fae-
ces in a similar way, with very similar results to earlier
studies. However, utilization of individual amino acids
from peptides was also compared, using faecal samples
from both vegetarians and omnivorous donors. The dif-
ferences may be explained by different permease mech-
anisms for peptides and amino acids. The effects of
monensin on NH3 production and amino acid dissimila-
tion were shown, providing clues about the biochemistry
and microbial ecology of amino acid dissimilation. Finally,
the bacteria that were enriched by growth on peptides or
amino acids as energy source were isolated and identified
based on 16S rRNA gene sequences. Similar methodology
in the rumen revealed the HAP population, with signifi-
cant implications for animal nutrition. The results imply
that, unlike in the rumen, there is no significant popula-
tion of ‘hyper-ammonia-producing’ bacteria [18]. Instead,
the species that were enriched by growth on peptides and
amino acids in the absence of carbohydrates include sev-
eral pathogenic species that have important implications
for health.
Ammonia production rates from Trypticase were higher
than from casein or from a corresponding amino acid
mixture. Casein is a protein that is atypically susceptible
to proteolytic degradation, so it may be concluded that
the first step of protein degradation to NH3 in theintestine, namely proteolysis, would generally be rate-lim-
iting. Smith & Macfarlane [1] also noted that NH3 produc-
tion was greater from peptides than amino acids, and
suggested that amino acid transport in the form of pep-
tides would be more energy-efficient than free amino
acids. NH3 production from amino acids was more sensi-
tive to the ionophore, monensin, than from peptides. The
greater sensitivity to monensin of amino acid compared to
peptide metabolism presumably reflects differences in
transport mechanisms into bacteria. Transport of peptides
in bacteria occurs predominantly by the ABC superfamily
of transporters, which use ATP to drive uptake [21,22],
while amino acid transport is more commonly linked to
proton or Na+ gradients [23]. As monensin catalyzes
Na+/H+ antiport in susceptible bacteria [24,25], this iono-
phore would therefore affect ion-linked amino acid trans-
port more than ATP-linked peptide transport.
Smith & Macfarlane [20] investigated the metabolism
of individual amino acids and a few pairs of amino acids
in slurries of human faecal bacteria, and found that Ser
was much more rapidly degraded than other amino
acids. The same authors investigated breakdown of a
complete mixture of free amino acids added to a fer-
menter that had been inoculated with a suspension of
human faecal bacteria. Ser was again degraded most rap-
idly, with Asp close behind, followed by Arg. Glu was
lost at less than one-quarter of the rate of Asp. Aromatic
amino acids were degraded most slowly. The results of
the present study were fairly similar, with the major
exceptions of Glu, which was broken down most rapidly
of all amino acids, and Lys, which was third or fourth
most rapidly degraded amino acid in our studies but
among the very lowest in Smith & Macfarlane [1]. While
there were differences between methods in the studies,
none offers an obvious explanation for these differences.
Table 3 Identity of bacteria isolated from peptides or amino acids enrichments
Isolate Vol/ diln Identification % Sim Phylum Class Order Accession no.
Peptides
1 O1/5 Clostridium perfringens 99 Firmicutes Clostridia Clostridiales GU968162
3 O1/5 Clostridium orbiscindens 99 Firmicutes Clostridia Clostridiales GU968163
5 O1/5 Shigella sonnei 98 Proteobacteria Gammaproteobacteria Enterobacteriales GU968164
6 O1/6 Enterococcus faecium 99 Firmicutes Bacilli Lactobacillales GU968165
8 O1/6 Bacteroides ovatus 99 Bacteroidetes Bacteroidia Bacteroidales GU968166
12 O2/5 C. orbiscindens 97 Firmicutes Clostridia Clostridiales 893 bp
13 O2/5 Clostridium innocuum 98 Firmicutes Clostridia Clostridiales GU968167
14 O2/5 B. ovatus 93 Bacteroidetes Bacteroidia Bacteroidales GU968168
15 O2/5 Blautia hydrogenotrophica 95 Firmicutes Clostridia Clostridiales GU968169
16 O2/6 C. orbiscindens 95 Firmicutes Clostridia Clostridiales 877 bp
17 O2/6 C. orbiscindens 99 Firmicutes Clostridia Clostridiales GU968170
21 V1/5 Bacteroides fragilis 99 Bacteroidetes Bacteroidia Bacteroidales GU968171
22 V1/5 Escherichia coli 99 Proteobacteria Gammaproteobacteria Enterobacteriales GU968172
23 V1/5 B. fragilis 98 Bacteroidetes Bacteroidia Bacteroidales GU968173
25 V1/6 B. fragilis 99 Bacteroidetes Bacteroidia Bacteroidales GU968174
27 V1/6 E. faecium 99 Firmicutes Bacilli Lactobacillales GU968175
Amino acids
29 O1/6 Shigella sp. 100 Proteobacteria Gammaproteobacteria Enterobacteriales GU968176
31 O1/6 Staphylococcus sp. 99 Firmicutes Bacilli Bacillales GU968177
33 O1/7 Shigella flexneri 98 Proteobacteria Gammaproteobacteria Enterobacteriales GU968178
34 O1/7 Eggerthella lenta 96 Actinobacteria Coriobacteridae Coriobacteriales GU968179
35 O1/7 S. flexneri 98 Proteobacteria Gammaproteobacteria Enterobacteriales GU968180
39 O2/6 Clostridium scindens 98 Firmicutes Clostridia Clostridiales GU968181
42 O2/7 Ruminococcus sp. 96 Firmicutes Clostridia Clostridiales One strand only
45 V1/5 E. coli 98 Proteobacteria Gammaproteobacteria Enterobacteriales GU968182
46 V1/5 E. coli 98 Proteobacteria Gammaproteobacteria Enterobacteriales GU968183
48 V1/5 E. coli 99 Proteobacteria Gammaproteobacteria Enterobacteriales GU968184
49 V1/5 E. coli 99 Proteobacteria Gammaproteobacteria Enterobacteriales GU968185
50 V1/6 E. coli 99 Proteobacteria Gammaproteobacteria Enterobacteriales 885 bp
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relatively low concentrations of amino acids in a
complete mixture and metabolized by a mixed micro-
biota would be the same as pure cultures metabolizing
the amino acid as a single substrate. This may be par-
ticularly relevant to Glu, which can be metabolized
either via the methylaspartate pathway in clostridia or
the hydroxyglutamate pathway in other species
[26,27], yet, in mixtures of amino acids in a mixed
culture with lower concentrations of Glu, Glu is most
probably deaminated or transaminated to α-oxogluta-
rate, which then enters and disperses into central
metabolic pathways.
The pattern of utilization of different amino acids
was similar whether the amino acids were free or
added as peptides. This provides a major contrast to
the rumen, where peptide-bound amino acids aremetabolized at different rates to free amino acids
and in a different order [28,29]. Peptide uptake can
predominate over amino acids in the ruminal bac-
teria of many animals, depending on the predomi-
nant microbiota that is present [30,31]. The present
results with the human microbiota suggest that, at
least in the individuals who provided samples here,
amino acid utilizing bacteria are more dominant
than peptide utilizers. The results with faecal sam-
ples from omnivores compared to vegetarians were
inconclusive in terms of NH3 production, but the
ranking order of dissimilation of different amino
acids was similar.
The influence of monensin was different with different
amino acids. Pro, Ala and Glu were inhibited most, with
Asp and Lys affected only to a minor extent. Once again,
the reason for this difference is unclear, but presumably
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others, or possibly a differential inhibition of species that
metabolize different amino acids [17,18].
One of the principal aims of this work was to investigate
if, by analogy with the rumen, HAP bacteria were present
in the human colon. Conditions of low-carbohydrate, high-
protein nutrient availability would favour bacteria able to
derive energy from amino acids, particularly in the distal
colon, but the general procedure of routinely adding sugars
to growth media may have concealed these bacteria in
culture-based studies. There had been a long-held assump-
tion for the rumen that a large group of bacteria identified
many years ago [32] was responsible for ruminal amino
acid deamination. Russell and his colleagues at Cornell
University challenged this assumption, and isolated less
numerous, but much more active, asaccharolytic, obligately
peptide-fermenting bacteria, the HAP species [18]. Growth
of HAP bacteria was inhibited by monensin, while the
more numerous NH3 producers were unaffected, yet NH3
production by the mixed ruminal microbiota was monen-
sin-sensitive. The present paper suggests that the human
microbiota has an NH3-producing activity about one-third
that of the rumen [17]. Nevertheless, it is clear that a sub-
stantial fraction of NH3 production from peptides and
amino acids is monensin-sensitive, so the possibility existed
that HAP species were present in human colonic digesta.
Bacteria capable of growth on peptides as energy
source were variable in number, averaging 3.5% of the
total viable count. This proportion is somewhat higher
than was found in ruminal digesta [16-18]. Actual num-
bers varied from 0.8 × 107 to 3.5 × 108 (g wet wt)-1,
which compares with 1011 per g dry weight on peptone
medium measured by Smith & Macfarlane [1]. Numbers
capable of growth on amino acids were almost as high
as those growing on Trypticase, which is a complete
contrast to the rumen, where numbers of amino acids
utilizers were two orders of magnitude less than Trypti-
case utilizers [17]. Thus, the bacterial population capable
of using protein breakdown products in the human
colon was more numerous than in the rumen, but less
active, and differed in its much lower preference for pep-
tides. As with the rumen, >90% of Trypticase utilizers
were sensitive to inhibition by monensin, indicating that
the bacteria were predominantly Gram-positive [33].
Smith & Macfarlane [1] enumerated amino acid-
fermenting colonic bacteria in medium containing peptone,
but did not isolate the bacteria concerned, concentrating
on bacteria growing on individual or Stickland pairs of
amino acids. The latter included mainly Clostridium spe-
cies, with Peptostreptococcus, Fusobacterium, Actinomyces,
Bacteroides, Megasphaera and Propionibacterium all repre-
sented. In the present study, the enrichments resulted in
the isolation of several groups of bacteria. None was a HAP
species, as all fermented glucose. Thus, the microbialecology of the rumen and the human colon are fundamen-
tally different in this respect. The species were also different
to those isolated by Smith & Macfarlane [1]. Clostridium
and Bacteroides were similarly predominant, though the
species were different. Notably, one of the bacteria enriched
was C. perfringens, which is a pathogen in animal species
and man [34,35]. One might conclude, therefore, that indi-
viduals consuming a low-carbohydrate, high-protein weight
loss diet would be vulnerable to increased numbers of
pathogens in the intestine, as well as the better character-
ized genotoxic and inflammatory products of amino acid
catabolism [2].
Conclusions
The metabolism of peptides and amino acids by human
faecal bacteria has many parallels with similar metabol-
ism in the rumen, except that the bacteria that grow on
these substrates are not specialist asaccharolytic (HAP)
species. Instead, they tend to be pathogens. Thus, the
implication is that when protein is the main substrate
for intestinal bacteria, not only are the products of pro-
tein fermentation toxic, the bacteria enriched by these
conditions may be harmful.
Methods
Donors
These experiments were carried out in compliance with
the Helsinki Declaration of Ethical Principles for Med-
ical Research Involving Human Subjects (http://www.
wma.net/en/30publications/10policies/b3/index.html).
Ethical approval was granted by the North of Scotland
Research Ethics Committee and all subjects provided
informed signed consent. Fresh faeces were obtained
from three omnivorous (O1 – O3) and three vegetarian
(V1 – V3) donors. No specific diets were given. O1 and
O2 were 33-year-old females, O3 was a 47-year-old
female, V1 and V3 were 56- and 26-year-old males, and
V2 was a 43-year-old female. None had received anti-
biotic therapy for 3 months before samples were given.
All samples were used fresh.
Measurement of ammonia production in faecal
suspensions in vitro
Faecal samples were diluted 1:10 wet weight in Chen &
Russell basal medium [36], the suspension was homoge-
nized in a stomacher, and 10 ml were added, under CO2,
to Hungate-type tubes containing 200 mg substrate with
or without 10 μl ethanol or 10 μl 5 mM monensin
(Sigma, Poole, Dorset, UK) in ethanol. This monensin
concentration (5 μM) was based on that used by Chen &
Russell [16,37], which is similar to the estimated monen-
sin concentration in vivo [38]. Tubes were incubated
in vitro under CO2 in a water bath at 37°C. Substrates
included casein (Sigma), TrypticaseW peptone (Becton
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and an amino acids mixture based on the composition of
casein. The amino acids mixture comprised Gibco casein
hydrolysate No. 5 (Life Technologies Ltd, Paisley, UK) plus
added L-tryptophan (0.87%), L-methionine (0.17%) and
L-cysteine (0.14%). One-ml samples were removed at 0, 2,
4, 6 and 8 h into 1.5-ml microcentrifuge tubes containing
0.25 ml 25% TCA. Samples were stored at 4°C, then centri-
fuged at 27,000 g for 20 min and ammonia was measured
on supernatants. Ammonia was determined in the super-
natant fluid by an automated phenol-hypochlorite method
[39] and protein was determined on the acid precipitate
using the Folin reagent [40]. For amino acids analysis, ali-
quots from the supernatant were dried under vacuum and
hydrolysed by a vapour phase method (constant boiling
HCl, 110°C, 18 h) and then derivatized with phenylisothio-
nate and analysed by HPLC [41].
Bacterial counts
Samples of faecal suspensions were diluted serially ten-fold
under CO2 in a vitamins/minerals medium with no carbo-
hydrate source, based on that described by Chen & Russell
[36]. The basal medium contained, per liter, 292 mg of
K2HPO4, 292 mg of KH2PO4, 480 mg of Na2SO4, 480 mg
of NaCl, 100 mg of MgSO4.7H2O, 55 mg anhydrous CaCl2,
1.0 ml of 0.1% resazurin, 600 mg of cysteine hydrochloride
and vitamins and minerals solutions [36]. The medium
was adjusted to pH 7.0 before autoclaving. These dilutions
were used to inoculate (1%, v/v) Hungate tubes containing
four different liquid media: A, complete liquid form of
medium M2 [42]; B, basal + 15 g/liter TrypticaseW peptone
(Becton Dickinson Microbiology Systems, Cockeysville,
MD 21030); C, medium B + 5 μM monensin; D, basal +
15 g l-1 Casamino acids (Difco, Becton Dickinson Europe,
38241 Meylan cedex, France). Five tubes were inoculated
for each dilution, the gas phase was 100% CO2, and tubes
were incubated at 37°C. The optical density at 650 nm was
determined periodically using an LKB Novaspec spectro-
photometer. Numbers were calculated using most-
probable-number tables [43], using a threshold of 0.1 as
positive for growth.
Isolation and identification of peptide and amino acid
utilisers
Cultures from the highest dilutions in medium B and D
were passaged once more in the same medium as before,
then streaked on the corresponding agar medium. Individ-
ual colonies of different morphology were picked off, trans-
ferred to the same medium and incubated at 37°C. The
isolation was then repeated. The ability of isolates to use
glucose for growth was examined by inoculating the isolates
into medium B or D to which 0.1% glucose had been
added, and comparing the optical density after 48 h incuba-
tion with the corresponding optical density in unmodifiedmedium. DNA was extracted from bacteria grown in both
media using QIAmp DNA stool mini kit (Qiagen, Crawley,
West Sussex, UK). Sequences of 16S rRNA genes were
amplified using universal primers, fD1 and rP2 [44], in a
mixture that contained 0.6 μM of each of the primers, 100
μM of each of the dNTPs, 2.5 mM MgCl2 in 1× buffer and
0.025 U/ml Taq polymerase (Bioline Ltd, London, UK).
Amplification was carried out using a BioRad Icycler and
the following programme: 94°C for 10 min; 35 cycles
of 94°C for 1 min, 60°C for 1 min, 72°C for 2 min;
then 72°C for 10 min, then 4°C. Amplification was
confirmed by agarose gel electrophoresis. PCR products
were cleaned up using WizardR SV Gel & PCR Clean-up
system (Promega). Sequencing was carried out with fD1
and rP2 primers as before, with 2 further forward (926f,
519f) and 2 reverse primers (926r, 519r) based on Lane et
al. [45]. Sequences were assembled with the Lasergene
programme [46] and bacteria identified with NCBI Blastn.
Where samples did not produce long enough sequences,
amplified DNA was cloned into the PCRW2.1-TOPO vector
(Invitrogen BV, Leek, the Netherlands). Plasmids were iso-
lated from recombinant colonies using WizardWPlus SV
Miniprep DNA Purification System (Promega). Plasmids
were checked for inserts by amplification with M13F and
M13R primers followed by agarose gel electrophoresis.
Plasmids which contained inserts were sequenced using
M13F and M13R primers initially then all 6 primers as used
before. Sequences were assembled and identified as before.
Full length or near full length 16S rRNA genes sequences
have been deposited in the GenBank database, with
accession numbers GU968162-GU968185.
Data analysis
Ammonia production rates were analysed by hierarchical
Analysis of Variance, with a between and within subject
stratum, with factors for diet (omnivore vs vegetarian),
medium (Trypticase vs amino acids) and monensin and
their interactions.
Production was linear during the incubations and rates
of NH3 production were determined by linear regression
and compared by ANOVA in Microsoft Excel.
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